The application of cerebrospinal fluid biomarkers in early diagnosis of Alzheimer disease - PubMed (original) (raw)
Review
The application of cerebrospinal fluid biomarkers in early diagnosis of Alzheimer disease
Kaj Blennow et al. Med Clin North Am. 2013 May.
Abstract
This article gives an updated account of the clinical application of cerebrospinal fluid (CSF) biomarkers for Alzheimer disease (AD). The clinically most relevant biomarkers, total tau, phospho-tau and Aβ42 are discussed, and how they may be used, together with other diagnostic investigations, to make a predementia diagnosis of AD. Recent findings in sporadic and genetic preclinical AD are also discussed and, more specifically, what the biomarkers have taught us on the sequence of events in the pathogenic process underlying AD.
Copyright © 2013 Elsevier Inc. All rights reserved.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical